Urinary Tract Infection News and Research

RSS
Urinary tract infections are a serious health problem affecting millions of people each year. Infections of the urinary tract are the second most common type of infection in the body. Urinary tract infections (UTIs) account for about 8.3 million doctor visits each year.* Women are especially prone to UTIs for reasons that are not yet well understood. One woman in five develops a UTI during her lifetime. UTIs in men are not as common as in women but can be very serious when they do occur.
Scientists uncover whole new way of treating antibiotic-resistant superbugs

Scientists uncover whole new way of treating antibiotic-resistant superbugs

Almost half of all long-stay nursing home residents visit ED every year regardless of cognitive status

Almost half of all long-stay nursing home residents visit ED every year regardless of cognitive status

Weekend effect in hospitals affect kidney stone treatment, outcomes

Weekend effect in hospitals affect kidney stone treatment, outcomes

SymCel joins global initiative to combat antibiotic resistance

SymCel joins global initiative to combat antibiotic resistance

Report: Patients still experience CLABSIs and CAUTIs in U.S. hospitals

Report: Patients still experience CLABSIs and CAUTIs in U.S. hospitals

Research: Impaired immune response significantly involved in rare autoimmune diseases

Research: Impaired immune response significantly involved in rare autoimmune diseases

Cranberry capsules more effective in lowering UTI risk than juice

Cranberry capsules more effective in lowering UTI risk than juice

Survey: 97% of patients concerned about cleaning and re-using catheters

Survey: 97% of patients concerned about cleaning and re-using catheters

Innovative microfiber pad could improve diagnosis of Urinary Tract Infection in infants and elderly patients

Innovative microfiber pad could improve diagnosis of Urinary Tract Infection in infants and elderly patients

Boehringer Ingelheim, Lilly announce availability of Synjardy tablets in U.S. pharmacies

Boehringer Ingelheim, Lilly announce availability of Synjardy tablets in U.S. pharmacies

People often end up in emergency room because of infection-related falls

People often end up in emergency room because of infection-related falls

New study calls for new treatments for carbapenem-resistant Enterobacteriaceae infection

New study calls for new treatments for carbapenem-resistant Enterobacteriaceae infection

EMPA-REG OUTCOME trial demonstrates superiority of Jardiance in T2D patients at risk for CV events

EMPA-REG OUTCOME trial demonstrates superiority of Jardiance in T2D patients at risk for CV events

Surgery delays for elderly patients with traumatic spinal cord injury

Surgery delays for elderly patients with traumatic spinal cord injury

STIOLTO RESPIMAT Inhalation Spray now available for treatment of COPD across the U.S.

STIOLTO RESPIMAT Inhalation Spray now available for treatment of COPD across the U.S.

UK Medical Device Companies in the Spotlight at the Medilink UK Awards 2015

UK Medical Device Companies in the Spotlight at the Medilink UK Awards 2015

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

Botulinum toxin A effective for treating bladder disorders

Botulinum toxin A effective for treating bladder disorders

Medilink UK Awards - The Winners 2015

Medilink UK Awards - The Winners 2015

New guide helps doctors, nurses to identify hospital patients who may benefit from urinary catheter

New guide helps doctors, nurses to identify hospital patients who may benefit from urinary catheter

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.